Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.
The chimeric oncogene Bcr-Abl is known to induce autonomous motility of leukemic cells. We show here that p210(bcr-abl) responsible for chronic myelogenous leukemia induces an amoeboid type of motility while p190(bcr-abl), associated with acute lymphoid leukemia, induces a rolling type of motility. We previously reported that p210(bcr-abl) activates RhoA and Rac1, while p190(bcr-abl) although devoid of a Dbl-homology (DH) domain activates Rac1, but not RhoA. We investigated the regulation of GDP/GTP exchange factor (GEF) activities in the Bcr-Abl complex. For that purpose, different GEF activity mutants of Vav and of Bcr-Abl were constructed and stably transfected in Ba/F3 cells. Using these mutants, we demonstrate that RhoA is exclusively activated by the DH domain of p210(bcr-abl), while Rac1 activation is mostly due to Vav. Inhibition of Rac1 by Vav GEF mutant leads to immobilization of cells. Vav depletion using shRNA also induces immobilization of cells and suppression of GTP-bound Rac1. RhoA inactivation induces the specific loss of amoeboid movements. These results suggest that Rac1 activation by Vav triggers the motility of Bcr-Abl-expressing Ba/F3 cells, while the specific amoeboid mode of motility induced by p210(bcr-abl) is a consequence of RhoA activation.
IPBC, CNRS UMR 6187, Université de Poitiers, Poitiers, France.
T
T
Daubon
J
J
Chasseriau
A
A
El Ali
J
J
Rivet
A
A
Kitzis
B
B
Constantin
N
N
Bourmeyster
D000818:Animals; D002460:Cell Line; D002464:Cell Migration Inhibition / Q000235:genetics; D002465:Cell Movement / Q000235:genetics / Q000502:physiology; D004268:DNA-Binding Proteins / Q000502:physiology*; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D020690:GTPase-Activating Proteins / Q000502:physiology*; D016313:Genes, abl; D020662:Guanine Nucleotide Exchange Factors / Q000037:antagonists & inhibitors / Q000502:physiology*; D051379:Mice; D051567:Proto-Oncogene Proteins c-vav / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000502:physiology; D034622:RNA Interference; D012097:Repressor Proteins / Q000502:physiology*; D020830:rac1 GTP-Binding Protein / Q000378:metabolism / Q000502:physiology
C513041:Arhgap35 protein, mouse; D004268:DNA-Binding Proteins; D020690:GTPase-Activating Proteins; D020662:Guanine Nucleotide Exchange Factors; D051567:Proto-Oncogene Proteins c-vav; D012097:Repressor Proteins; D016044:Fusion Proteins, bcr-abl; D020830:rac1 GTP-Binding Protein